Journal article
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats
European journal of pharmacology, Vol.650(2), pp.556-562
2011
DOI: 10.1016/j.ejphar.2010.10.047
PMCID: PMC3016620
PMID: 21040718
Abstract
We have previously shown that treating streptozotocin-induced diabetic rats, an animal model of type 1 diabetes, with Ilepatril (an inhibitor of neutral endopeptidase and angiotensin converting enzyme (ACE)) improves vascular and neural function. In this study we sought to determine the individual effect of inhibition of neutral endopeptidase and ACE on diabetes-induced vascular and neural dysfunction. After 4
weeks of untreated diabetes, rats were treated for 12
weeks with Ilepatril, Enalapril (ACE inhibitor) or Candoxatril (neutral endopeptidase inhibitor) followed by analysis of neural and vascular function. Diabetes caused slowing of motor and sensory nerve conduction, thermal hypoalgesia, reduction in intraepidermal nerve fiber density in the hindpaw and impairment in vascular relaxation to acetylcholine and calcitonin gene-related peptide in epineural arterioles of the sciatic nerve and to atrial natriuretic peptide and calcitonin gene-related peptide in renal arteries. Inhibition of neutral endopeptidase or ACE improved neural function; however, dual inhibition of neutral endopeptidase and ACE with Ilepatril tended to have the greatest efficacy. Ilepatril and Candoxatril treatment of diabetic rats was more efficacious in improving vascular responsiveness in epineurial arterioles than treatment with Enalapril. Ilepatril, Enalapril or Candoxatril treatment of diabetic rats were all efficacious in renal arteries. These studies suggest that combination therapy may be the most effective approach for treatment of diabetic neural and vascular complications.
Details
- Title: Subtitle
- Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats
- Creators
- Christine L Oltman - Department of Veterans Affairs Iowa City Health Care System, University of Iowa, Iowa City, IA, 52246, United StatesEric P Davidson - Department of Internal Medicine, University of Iowa, Iowa City, IA, 52246, United StatesLawrence J Coppey - Department of Internal Medicine, University of Iowa, Iowa City, IA, 52246, United StatesTravis L Kleinschmidt - Department of Veterans Affairs Iowa City Health Care System, University of Iowa, Iowa City, IA, 52246, United StatesBrian Dake - Department of Internal Medicine, University of Iowa, Iowa City, IA, 52246, United StatesMark A Yorek - Department of Veterans Affairs Iowa City Health Care System, University of Iowa, Iowa City, IA, 52246, United States
- Resource Type
- Journal article
- Publication Details
- European journal of pharmacology, Vol.650(2), pp.556-562
- DOI
- 10.1016/j.ejphar.2010.10.047
- PMID
- 21040718
- PMCID
- PMC3016620
- NLM abbreviation
- Eur J Pharmacol
- ISSN
- 0014-2999
- eISSN
- 1879-0712
- Publisher
- Elsevier B.V
- Language
- English
- Date published
- 2011
- Academic Unit
- Fraternal Order of Eagles Diabetes Research Center; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984094718502771
Metrics
9 Record Views